cholecystokinin (27-33) has been researched along with meglumine in 1 studies
| Studies (cholecystokinin (27-33)) | Trials (cholecystokinin (27-33)) | Recent Studies (post-2010) (cholecystokinin (27-33)) | Studies (meglumine) | Trials (meglumine) | Recent Studies (post-2010) (meglumine) |
|---|---|---|---|---|---|
| 39 | 0 | 0 | 4,168 | 413 | 1,399 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horwell, DC | 1 |
1 other study(ies) available for cholecystokinin (27-33) and meglumine
| Article | Year |
|---|---|
Development of CCK-B antagonists.
Topics: Amino Acid Sequence; Animals; Binding Sites; Blood-Brain Barrier; Cerebral Cortex; Cholecystokinin; Drug Design; Indoles; Meglumine; Mice; Molecular Sequence Data; Peptide Fragments; Receptors, Cholecystokinin; Sincalide; Structure-Activity Relationship | 1991 |